RAPT Therapeutics Reports Positive Initial Data From Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications Portfolio News / By Karina Tin November 16, 2020 RAPT Therapeutics Reports Positive Initial Data From Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications Read More »
RAPT Therapeutics Reports Third Quarter 2020 Financial Results Portfolio News / By Karina Tin November 16, 2020 RAPT Therapeutics Reports Third Quarter 2020 Financial Results Read More »
NGM Bio Presents Phase 1 Safety and Pharmacokinetics Data for NGM621, an Anti-Complement C3 Antibody, in Patients with Geographic Atrophy Portfolio News / By Karina Tin November 13, 2020 NGM Bio Presents Phase 1 Safety and Pharmacokinetics Data for NGM621, an Anti-Complement C3 Antibody, in Patients with Geographic Atrophy Read More »
Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin November 12, 2020 Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress Read More »
NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results Portfolio News / By Karina Tin November 12, 2020 NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results Read More »
eFFECTOR Announces Dosing of First Breast Cancer Patient with Tomivosertib in Combination with Chemotherapy Portfolio News / By Karina Tin November 12, 2020 eFFECTOR Announces Dosing of First Breast Cancer Patient with Tomivosertib in Combination with Chemotherapy Read More »
ORIC Pharmaceuticals Reports Third Quarter 2020 Financial and Operational Update Portfolio News / By Karina Tin November 5, 2020 ORIC Pharmaceuticals Reports Third Quarter 2020 Financial and Operational Update Read More »
Surrozen Appoints Charles Williams as Chief Financial Officer Portfolio News / By Karina Tin October 30, 2020 Surrozen Appoints Charles Williams as Chief Financial Officer Read More »
Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial Results Portfolio News / By Karina Tin October 29, 2020 Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial Results Read More »
Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers Portfolio News / By Karina Tin October 24, 2020 Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers Read More »
